의약품 관련 법령
Interpretation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-12-13 | 조회수 | 1,319 |
국가정보 | 북 아메리카>미국 | ||
출처 | FDA | ||
원문 | https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM490264.pdf | ||
첨부파일 |
Interpretation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009
- 이전글 The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers
- 다음글 Data Integrity and Compliance With Current Good Manufacturing Practice Guidance for Industry